{"schema_version":"secwatch.filing_event.v1","accession":"0001567264-25-000042","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2025-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.809503+00:00","generated_at":"2026-05-20T23:59:19.038921+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Intensity Therapeutics receives Nasdaq non-compliance notice for stockholders' equity","bullets":["Nasdaq notified company on May 19, 2025 of failure to meet minimum $2.5M stockholders' equity requirement.","Company has until July 3, 2025 to submit a plan to regain compliance.","If plan accepted, Nasdaq may grant up to 180-day extension from notice date.","Failure could lead to delisting of common stock (INTS); no immediate effect on listing."],"urls":{"canonical":"https://secwatch.observer/filing/0001567264-25-000042","json":"https://secwatch.observer/filing/0001567264-25-000042.json","markdown":"https://secwatch.observer/filing/0001567264-25-000042.md","text":"https://secwatch.observer/filing/0001567264-25-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000156726425000042/0001567264-25-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000156726425000042/intensity-20250519.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T23:59:19.038921+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"140b17da25f6014e0f7490d22d58b924db3cd671","claim":"INTENSITY THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 19, 2025, Intensity Therapeutics, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market (the “Notice”) based on the information provided in the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2025. Nasdaq Listing Rule 5550(b)(1) requires that companies listed on The Nasdaq Capital Market with a market value of listed securities o","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567264/000156726425000042/0001567264-25-000042-index.htm","confidence":0.98,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}